Replies to post #121395 on Biotech Values

[DewDiligence]

Re: Arixtra

interesting not a single orange book patent on complex product Fondaparinux

Arixtra’s US patent expired in 2003 and the 5-year Hatch-Waxman exclusivity granted to an NME expired in 2006.

The possibility of generic Arixtra is of little concern to MNTA investors, IMO, for the reasons mentioned in #msg-40342721.

[sodrock]

a little history lesson.. Arixtra was a Sanofi product and when Sanofi and Aventis merged they opted to continue promoting Aventis's Lovenox over Arixtra and sold that franchise.